There is one clinical trial.
A pilot study to investigate the effects of the prone positioning (PP) on hospital patients diagnosed with COVID-19 pneumonia. Investigators that early self-proning may prevent intubation and improve mortality in patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2). Up to 100 participants with a primary diagnosis of confirmed COVID-19 pneumonia will be enrolled to the study. All participants will be screened and those that meet inclusion and exclusion criteria will be enrolled to one of two groups: one with prone positioning (on the belly) and the other with standard supine positioning (on the back). The patient and nursing staff will monitor times spent in various positions. Outcome measures include incidence of intubation, max oxygen requirements, length of hospital stay, ventilator-free days, worsening of oxygenation saturation, and mortality.
Description: Incidence of intubation
Measure: Incidence of intubation Time: Through study completion, an average of 6 daysDescription: Measure of maximum oxygen requirements
Measure: Maximum oxygen requirement Time: Through study completion, an average of 6 daysDescription: Measured in days of hospitalization
Measure: Length of Stay Time: Through study completion, an average of 6 daysDescription: Measured in days not on a ventilator
Measure: Ventilator-free days Time: Through study completion, an average of 6 daysDescription: Whether or not the participant met treatment failure descriptions
Measure: Treatment failure of prone positioning due to worsening SpO2 status while prone Time: Through study completion, an average of 6 daysDescription: Whether or not the participant died while hospitalized
Measure: Mortality Time: Through study completion, an average of 6 days